PBSVPharma-Bio Serv, Inc.vs its industry peers
A metric-by-metric comparison of Pharma-Bio Serv, Inc. against SIC 8742 — valuation, growth, profitability, quality and total return, with each figure's rank within the peer group. Every value is Go-computed from SEC filings and delayed prices; ranks are sorted positions within the group only — descriptive, not advice.
| Company | Market cap | P/E (TTM) | P/B | P/S | Revenue growth (YoY) | Earnings growth (YoY) | EBIT margin | ROE | ROIC | Piotroski F | 1y total return | Dividend yield |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| PBSVThis | — | — | — | — | -5.3%#3 | 87.1%#2 | -7.1%#2 | -1.0%#3 | — | — | — | — |
| LICN | $6M#3 | — | 0.1x#1 | 6.9x#2 | — | -257.7%#9 | -2233.5%#7 | -31.1%#5 | -40.0%#3 | — | -77.7%#1 | — |
| NAFS | — | — | — | — | -85.7%#8 | 85.5%#3 | -25766.4%#9 | — | — | — | — | — |
| NORD | — | — | — | — | 100.0%#2 | -37.9%#7 | -87420.0%#10 | -6.2%#4 | — | — | — | — |
| PHCI | — | — | — | — | 1129.1%#1 | 96.5%#1 | -226.0%#5 | — | — | — | — | — |
| RDSC | — | — | — | — | — | — | -61.0%#4 | -306.7%#7 | — | — | — | — |
| RMR | — | 16.0x#1 | — | — | -5.8%#4 | -23.9%#5 | 22.9%#1 | 7.8%#1 | 16.6%#1 | — | — | — |
| ROMA | $146M#1 | — | 15.2x#3 | 119.8x#3 | -22.2%#6 | 1.6%#4 | -315.0%#6 | -36.4%#6 | — | — | — | — |
| RYOJ | $43M#2 | 370.0x#2 | 7.0x#2 | 4.6x#1 | -19.4%#5 | -91.0%#8 | -8.1%#3 | 2.0%#2 | -22.3%#2 | — | — | — |
| SATT | — | — | — | — | -73.6%#7 | -27.8%#6 | -2924.1%#8 | — | — | — | — | — |
Peer set: US filers sharing this company's SEC industry classification (SIC 8742). SIC is coarse — conglomerates and multi-segment companies map imperfectly. Values from SEC filings + delayed prices; ranks are within-group positions only. Market cap, P/E, P/B, P/S, 1y total return and dividend yield are computed from each member's latest snapshot price when the table is built (see as-of; snapshot prices can lag) — not live. Some peers are still being computed, so this table covers part of the group and ranks are within the rows shown; it fills in shortly. This table timed out mid-build, so it covers part of the group; ranks are within the rows shown and it fills in shortly. Table built 2026-09-28.
Source: SEC XBRL filings + delayed prices · ranks are within-group positions · For reference only · Not investment advice